TOP PICK
The oldest manufacturer of syringes and other medical devices. There is good growth in emerging countries. They will pay down debt and have attractive dividend growth. (Analysts’ price target is $263.10)
TOP PICK
They have good growth opportunities in BC and Arizona. Over 45 years they have raised their dividend. 16 times earnings. A well managed company. If there is more volatility this is a good place to be. (Analysts’ price target is $48.20)
TOP PICK
It has lagged the banking group. In 2018 they were busy doing acquisitions in south America. They have a good focus on costs. They will integrate their acquisitions. This is a good time to get in. (Analysts’ price target is $81.78)